139 443

Cited 10 times in

Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea

Authors
Chang, JY | Yu, J | Chung, BH | Yang, J | Kim, SJ | Kim, CD | Lee, SH | Lee, JS | Kim, JK | Jung, CW | Oh, CK  | Yang, CW
Citation
PloS one, 12(8). : e0183826-e0183826, 2017
Journal Title
PloS one
ISSN
1932-6203
Abstract
BACKGROUND: The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear.
METHODS: We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy.
RESULTS: Most patients (n = 621, 97.6%) received induction therapy often comprising basiliximab (n = 542, 85.2%). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4%), but its proportion decreased by 14% (81.4% to 67.5%) after 1 year. Almost 40% of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2% within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8%), followed by infection (112, 29.6%). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1%).
CONCLUSION: The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.
MeSH

DOI
10.1371/journal.pone.0183826
PMID
28846737
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Ajou Authors
오, 창권
Full Text Link
Files in This Item:
28846737.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse